Please login to the form below

Not currently logged in
Email:
Password:

Hanover appoints new associate director

Jim Baxter joins from Tonic Life to lead market access and brand communications

Hanover, Jim Baxter

Hanover has appointed Jim Baxter as a new associate director in its healthcare division, where he will focus on market access and brand communications.

Baxter joins the agency from Tonic Life Communications, where he led UK and pan-European communications strategies.

Previously he spent five years in-house with Schering-Plough and MSD, working on brand communications across immunology, CVD, respiratory, virology and addiction portfolios.

Commenting on his appointment, Baxter said: “Increasingly, there is a need for consultancies to provide tailored communications solutions that address regulatory, reimbursement and brand awareness challenges in a joined up and holistic manner.

“Hanover's integrated public affairs, media relations, policy and market access experience in London and Brussels is perfectly positioned to deliver bespoke communications solutions - ultimately improving patient access to effective medicines.”

Hanover aims to use Baxter's experience in strategic brand communications, advocacy engagement and issue management to expand its UK and pan-European market access and brand communications business.

“In the UK and across Europe clients are searching for coherent brand value propositions that connect with both prescribers and payers alike, and are looking for agencies that can deliver integrated communications programmes to match,” said Andrew Harrison, director of healthcare, Hanover.

“Jim's hire is a direct response to brand clients asking for more integrated services from policy-led engagement with payers and advocates through to traditional PR and communications.

“Sometimes there might be a good clinical brand story, but where we have the greatest traction for clients is combining this with getting the NHS to see the product as a way of achieving its management and policy goals.”

13th December 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics